TEST MULTIDROGHE ONE STEP CON BICCHIERINO
INTEGRATO (URINA)
ONE STEP SCREEN TEST PANEL WITH INTEGRATED CUP
(URINE)
Manuale d’uso - User manual
PER USO PROFESSIONALE
FOR PROFESSIONAL USE
ATTENZIONE: Gli operatori devono leggere e capire completamente questo manuale prima di utilizzare il prodotto.
ATTENTION: The operators must carefully read and completely understand the present manual
before using the product.
30°C
2°C
M-24546-M-Rev.2-07.18
24546
Innovacon, Inc.
9975 Summers Ridge Road
San Diego, CA 92121, USA
Made in China (P.R.C.)
Multi-Drug One Step Screen Test Panel with integrated cup (Urine)
Package insert for testing of any combination of the following drugs:
Amphetamine 500, Cocaine, Marijuana, Methadone, Methamphetamine 500, Methylenedioxymethamphetamine,
Morphine 300.
Including Specimen Validity Tests (S.V.T.) for Oxidants/ Pyridinium Chlorochromate (OX/PCC), Specic Gravity (S.G.),
pH, Nitrite (NIT), Glutaraldehyde (GLUT) and Creatinine (CRE).
A rapid, one step screen test for the simultaneous, qualitative detection of multiple drugs and metabolites in human
urine. For medical and other professional in vitro diagnostic use only.
INTENDED USE & SUMMARY
Urine based screen tests for multiple drugs of abuse range from simple immunoassay tests to complex analytical
procedures. The speed and sensitivity of immunoassays have made them the most widely accepted method to screen
urine for multiple drugs of abuse.
The Multi-Drug One Step Screen Test Panel with integrated cup (Urine) is a lateral ow chromatographic immunoassay
for the qualitative detection of following drugs without the need of instruments.
This test will detect other related compounds, please refer to the Analytical Specicity table in this package insert.
This assay provides only a preliminary analytical test result. A more specic alternate chemical method must
be used in order to obtain a conrmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is
the preferred conrmatory method. Clinical consideration and professional judgment should be applied to any
drug of abuse test result, particularly when preliminary positive results are indicated.
S.V.T. SUMMARY
Each S.V.T. strip contains chemically treated reagent pads. Three to ve minutes following the activation of the reagent
pads by the urine sample, the colors that appear on the pads can be compared with the printed color chart card. The
color comparison provides a semi-quantitative screen for any combination of oxidants/pyridinium chlorochromate
(PCC), specic gravity, pH, nitrite, glutaraldehyde and creatinine in human urine which can help assess the integrity
of the urine sample.
PRINCIPLE
The Multi-Drug One Step Screen Test Panel with integrated cup (Urine) is an immunoassay based on the principle of
competitive binding. Drugs which may be present in the urine specimen compete against their respective drug conjugate
for binding sites on their specic antibody.
During testing, a urine specimen migrates upward by capillary action. A drug, if present in the urine specimen below
its cut-o concentration, will not saturate the binding sites of its specic antibody coated on the particles. The antibody
coated particles will then be captured by the immobilized drug conjugate and a visible colored line will show up in the
test line region of the specic drug strip. The colored line will not form in the test line region if the drug level is above its
cut-o concentration because it will saturate all the binding sites of the antibody coated on the particles.
A drug-positive urine specimen will not generate a colored line in the specic test line region of the strip because of
drug competition, while a drug-negative urine specimen or a specimen containing a drug concentration less than the
cut-o will generate a line in the test line region. To serve as a procedural control, a colored line will always appear at
the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.
S.V.T. PRINCIPLE
Adulteration is the tampering of a urine specimen with the intention of altering the test results.
The use of adulterants can cause false negative results in drug tests by either interfering with the screening test and/
or destroying the drugs present in the urine. Dilution may also be employed in an attempt to produce false negative
drug test results.
One of the best ways to test for adulteration or dilution is to determine certain urinary characteristics such as pH and
specic gravity and to detect the presence of oxidants/PCC, specic gravity, pH, nitrite, glutaraldehyde and creatinine
in urine.
• Oxidants/PCC (Pyridinium chlorochromate) tests for the presence of oxidizing agents such as bleach and hydrogen
peroxide. Pyridinium Chlorochromate is a commonly used adulterant.
2
or PCC.
1
(ng/mL)
Normal human urine should not contain oxidants
8
Page 3
9
ENGLISH
• Specic gravity tests for sample dilution. The normal range is from 1.003 to 1.030. Values outside this range may be
the result of specimen dilution or adulteration.
• pH tests for the presence of acidic or alkaline adulterants in urine. Normal pH levels should be in the range of 4.0 to
9.0. Values outside of this range may indicate the sample has been altered.
• Nitrite tests for commonly used commercial adulterants such as Klear or Whizzies. They work by oxidizing the major
cannabinoid metabolite THC-COOH.3 Normal urine should contain no trace of nitrite. Positive results generally indicate
the presence of an adulterant.
• Glutaraldehyde tests for the presence of an aldehyde. Adulterants such as UrinAid and Clear Choice contain
glutaraldehyde which may cause false negative screening results by disrupting the enzyme used in some immunoassay
tests.2 Glutaraldehyde is not normally found in urine; therefore, detection of glutaraldehyde in a urine specimen is
generally an indicator of adulteration.
• Creatinine is a waste product of creatine, an amino acid contained in muscle tissue and found in urine.
1
A person
may attempt to foil a test by drinking excessive amounts of water or diuretics such as herbal teas to “ush” the system.
Creatinine and specic gravity are two ways to check for dilution and ushing, which are the most common mechanisms
used in an attempt to circumvent drug testing. Low creatinine and specic gravity levels may indicate dilute urine. The
absence of creatinine (< 5 mg/dL) is indicative of a specimen not consistent with human urine.
REAGENTS
Each test contains specic drug antibody-coupled particles and corresponding drug-protein conjugates. A goat antibody
is employed in each control line.
S.V.T. REAGENTS
Adulteration PadReactive indicatorBuers and non-reactive ingredients
• For medical and other professional in vitro diagnostic use only. Do not use after the expiration date.
• The test panel should remain in the sealed pouch until use.
• All specimens should be considered potentially hazardous and handled in the same manner as an infectious agent.
• The used test panel should be discarded according to local regulations.
STORAGE AND STABILITY
Store as packaged in the sealed pouch either at room temperature or refrigerated (2-30°C). The test panel is stable
through the expiration date printed on the sealed pouch. The test panel must remain in the sealed pouch until use. DO
NOT FREEZE. Do not use beyond the expiration date.
SPECIMEN COLLECTION AND PREPARATION
Urine Assay
The urine specimen must be collected in a clean and dry container. Urine collected at any time of the day may be used.
Urine specimens exhibiting visible precipitates should be centrifuged, ltered, or allowed to settle to obtain a clear
supernatant for testing.
Specimen Storage
Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For prolonged storage, specimens may
be frozen and stored below -20°C. Frozen specimens should be thawed and mixed well before testing. When tests
include S.V.T., storage of urine specimens should not exceed 2 hours at room temperature or 4 hours refrigerated prior
to testing. For best results, test specimens immediately following collection.
MATERIALS
Materials Provided
• Cups with multi-drug panels • Security seal labels • Keys
• SVT/Adulterant color chart (if applicable) • Package insert
Materials Required But Not Provided
• Timer
Page 4
ENGLISH
DIRECTIONS FOR USE
Allow the test cup, urine specimen, and/or controls to equilibrate to room temperature (15-30°C) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the cup from the sealed pouch and use it as soon
as possible.
2. Remove the key by twisting it from the center of the cup cap.
3. Collect specimen in the cup and secure the cap tightly by pressing down on the pull tab until an audible click is heard.
4. Check the temperature label (Temp Label) up to 4 minutes after specimen collection. A green color will appear to
indicate the temperature of the urine specimen. The proper range for an unadulterated specimen is 33-38°C (91-100°F).
5. Date and initial the security seal label then place it over the cap.
6. Place the cup on a at surface and push the key into the socket of the cup to initiate the test. Start the timer.
7. Remove the peel o label covering the test results. Read the adulteration strip between 3 and 5 minutes.
8. Compare the colors on the adulteration strip to the enclosed color chart. If the result indicates adulteration, do not
interpret the drug test results. Either retest the urine or collect another specimen.
9. Read the drug strip results at 5 minutes. The drug strip results remain stable for up to sixty minutes.
10
INTERPRETATION OF RESULTS
(Please refer to the illustration above)
NEGATIVE:* A colored line in the control line region (C) and a colored line in the test line region (T) for a specic
drug indicate a negative result. This indicates that the drug concentration in the urine specimen is below the designated
cut-o level for that specic drug.
*NOTE: The shade of color in the test region (T) may vary, but it should be considered negative whenever there is
even a faint colored line.
POSITIVE: A colored line in the control line region (C) but no line in the test line region (T) for a specic drug
indicates a positive result. This indicates that the drug concentration in the urine specimen exceeds the designated
cut-o for that specic drug.
INVALID: Control line fails to appear. Insucient specimen volume or incorrect procedural techniques are the most
likely reasons for control line failure. Review the procedure and repeat the test using a new test panel. If the problem
persists, discontinue using the lot immediately and contact your local distributor.
SVT/ADULTERANT INTERPRETATION
(Please refer to the color chart)
Semi-quantitative results are obtained by visually comparing the reacted color blocks on the strips to the printed color
blocks on the color chart. No instrumentation is required.
QUALITY CONTROL
A procedural control is included in the test. A colored line appearing in the control line region (C) is considered an internal
procedural control. It conrms sucient specimen volume, adequate membrane wicking and correct procedural technique.
Control standards are not supplied with this kit; however, it is recommended that positive and negative controls be tested
as good laboratory practice to conrm the test procedure and to verify proper test performance.
LIMITATIONS
1. The Multi-Drug One Step Screen Test Panel with integrated cup (Urine) provides only a preliminary analytical result.
A more specic chemical method must be used to obtain a conrmed result. Gas chromatography/mass spectrometry
(GC/MS) is the preferred conrmatory method.
2. It is possible that technical or procedural errors, as well as other interfering substances in the urine specimen may
cause erroneous results.
4, 5
Page 5
11
ENGLISH
3. Adulterants, such as bleach and/or alum, in urine specimens may produce erroneous results regardless of the analytical
method used. If adulteration is suspected, the test should be repeated with another urine specimen.
4. A positive result indicates presence of the drug or its metabolites but does not indicate level of intoxication, administration
route or concentration in urine.
5. A negative result may not necessarily indicate drug-free urine. Negative results can be obtained when drug is present
but below the cut-o level of the test.
6. The test does not distinguish between drugs of abuse and certain medications.
7. A positive result might be obtained from certain foods or food supplements.
S.V.T. ADULTERATION LIMITATIONS
1. The adulteration tests included with this product are meant to aid in the determination of abnormal specimens. While
comprehensive, these tests are not meant to be an “all-inclusive” representation of possible adulterants.
2. Oxidants/PCC: Normal human urine should not contain oxidants or PCC. The presence of high levels of antioxidants
in the specimen, such as ascorbic acid, may result in false negative results for the oxidants/PCC pad.
3. Specic Gravity: Elevated levels of protein in urine may cause abnormally high specic gravity values.
4. Nitrite: Nitrite is not a normal component of human urine. However, nitrite found in urine may indicate urinary tract
infections or bacterial infections. Nitrite levels of > 20 mg/dL may produce false positive glutaraldehyde results.
5. Glutaraldehyde: Is not normally found in urine. However certain metabolic abnormalities such as ketoacidosis (fasting,
uncontrolled diabetes or high-protein diets) may interfere with the test results.
6. Creatinine: Normal creatinine levels are between 20 and 350 mg/dL. Under rare conditions, certain kidney diseases
may show dilute urine.
PERFORMANCE CHARACTERISTICS
Accuracy
A side-by-side comparison was conducted using the Multi-Drug One Step Screen Test Panel with integrated cup (Urine)
and commercially available drug rapid tests. Testing was performed on approximately 300 specimens previously collected
from subjects present for drug screen testing. Presumptive positive results were conrmed by GC/MS. The following
results were tabulated:
% Agreement with Commercial Kit
Specimen AMP 500COCTHCMTDMET 500MDMAMOP 300
Positive*>99%>99%89%>99%96%95%
Negative*99%99%>99%80%>99%>99%
Total*99%99%94%87%98%97%
* NOTE: Commercial kit unavailable for comparison testing.
% Agreement with GC/MS
Specimen AMP 500COCTHCMTDMET 500MDMAMOP 300
Positive95%95%95%93%99%99%98%
Negative>99%>99%95%>99%>99%99%97%
Total98%98%95%97%99%99%97%
Analytical Sensitivity
A drug-free urine pool was spiked with drugs to the concentrations at ± 50% cut-o and ± 25%
cut-o. The results are summarized below.
The following tables lists the concentration of compounds (ng/mL) that are detected positive in urine by the Multi-Drug
One Step Screen Test Panel with integrated cup (Urine) at 5 minutes.
A study was conducted to determine the cross-reactivity of the test with compounds in either drug-free urine or
Amphetamine 500, Cocaine, Marijuana, Methadone, Methamphetamine 500, Methylenedioxymethamphetamine,
Morphine 300 positive urine. The following compounds show no cross-reactivity when tested with the Multi-Drug One
Step Screen Test Panel with integrated cup (Urine) at a concentration of 100 μg/mL.